Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences

Amyloid Load in the Down syndrome population measured with [11C]PiB PET

Matthew Zammit, Charles Laymon, Karly Cody, Ann Cohen, Dana Tudorascu, Sterling Johnson, Tobey Betthauser, Todd Barnhart, Dhanabalan Murali, Charles Stone, Davneet Minhas, William Klunk, Banjamin Handen and Bradley Christian
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 251;
Matthew Zammit
3University of Wisconsin-Madison Madison WI United States
4University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Laymon
1University of Pittsburgh Pittsburgh PA United States
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karly Cody
3University of Wisconsin-Madison Madison WI United States
4University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Cohen
1University of Pittsburgh Pittsburgh PA United States
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dana Tudorascu
1University of Pittsburgh Pittsburgh PA United States
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sterling Johnson
3University of Wisconsin-Madison Madison WI United States
4University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tobey Betthauser
3University of Wisconsin-Madison Madison WI United States
4University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Todd Barnhart
3University of Wisconsin-Madison Madison WI United States
4University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dhanabalan Murali
3University of Wisconsin-Madison Madison WI United States
4University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Stone
3University of Wisconsin-Madison Madison WI United States
4University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Davneet Minhas
1University of Pittsburgh Pittsburgh PA United States
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William Klunk
1University of Pittsburgh Pittsburgh PA United States
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Banjamin Handen
1University of Pittsburgh Pittsburgh PA United States
2University of Pittsburgh Pittsburgh PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bradley Christian
3University of Wisconsin-Madison Madison WI United States
4University of Wisconsin-Madison Madison WI United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

251

Background: Individuals with Down syndrome (DS) are at increased risk of developing Alzheimer’s disease (AD) and show the earliest signs of amyloid-β (Aβ) deposition in the striatum. The metric for tracking amyloid burden using PET radiotracers frequently uses average SUVr in signature regions of the brain specific to Aβ deposition. An alternative index of amyloid load (AβL) was recently developed (Whittington 2018) as a template-based approach of quantifying Aβ burden from static PET data with high sensitivity to detect Aβ change. The algorithm determines AβL and a non-specific binding coefficient (ns) given inputs of SUVr and canonical images of Aβ carrying capacity (K) and tracer non-specific binding (NS). Objective: The purpose of this study was to implement the AβL algorithm in the DS population using DS-specific [11C]PiB PET templates for spatial normalization, K and NS with the inclusion of striatal PiB binding in the model parameters. Additionally, a cutoff for PiB(+) based on AβL were determined from the dataset.

Methods: Participants with DS (N=100; 38.5±8.2 yrs) were enrolled as non-demented, with some converting to MCI and AD during the course of the study. All participants underwent a 50-70 minute [11C]PiB scan in addition to T1w-MRI. A subset of participants (n=52, 35, and 7) underwent two, three, and four PiB scans, respectively (2.3±0.6 years apart). ROI definition was performed through segmentation of the T1w-MRI using FreeSurfer v5.3.0. SUVr images were generated from the PET data using cerebellar gray matter as the region for normalization. Global PiB was computed as the average SUVr from the striatum and cortex. A sigmoidal growth curve (fit by the logistic growth model of Aβ accumulation) describing AD chronology (30 year scale) was generated by integrating longitudinal rates of striatal PiB change (Figure 1). The PET data were spatially normalized to MNI152 space using a DS-specific PiB PET template, smoothed with a 4 mm Gaussian kernel, and a time point in AD chronology was determined for each participant. Parametric images of K and NS were generated by applying the logistic growth model at the voxel level to the SUVr data. AβL and ns were calculated using the AβL algorithm for each participant. Thresholds for PiB(+) were determined from sparse k-means clustering with resampling as implemented on SUVr data.

Results: DS-specific maps for K and NS (Figure 2) were consistent with the known Aβ pathology (with highest voxel intensities in the striatum) and white matter PiB binding. A strong positive correlation was observed between AβL and global PiB SUVr (Pearson’s r = 0.97) and no correlation was observed between ns and SUVr (r = -0.09; Figure 3). An AβL cutoff for PiB(+) of 23.9% was determined from k-means clustering. Conclusion: These results highlight the promise of AβL for quantification of Aβ burden in DS. Unique to this population (compared to sporadic AD) is the striatum displaying the highest carrying capacity. Analysis is ongoing to evaluate longitudinal change in AβL in this cohort to better characterize the natural history of Aβ in DS.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Amyloid Load in the Down syndrome population measured with [11C]PiB PET
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Amyloid Load in the Down syndrome population measured with [11C]PiB PET
Matthew Zammit, Charles Laymon, Karly Cody, Ann Cohen, Dana Tudorascu, Sterling Johnson, Tobey Betthauser, Todd Barnhart, Dhanabalan Murali, Charles Stone, Davneet Minhas, William Klunk, Banjamin Handen, Bradley Christian
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 251;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Amyloid Load in the Down syndrome population measured with [11C]PiB PET
Matthew Zammit, Charles Laymon, Karly Cody, Ann Cohen, Dana Tudorascu, Sterling Johnson, Tobey Betthauser, Todd Barnhart, Dhanabalan Murali, Charles Stone, Davneet Minhas, William Klunk, Banjamin Handen, Bradley Christian
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 251;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences

  • PET quantifies target engagement of MAGL therapeutics for Alzheimer’s disease
  • CSF Shunt Scintigraphy - spills and stops, review of protocols via challenging cases
  • A Critical Assessment of PET Radiotracers in the Imaging of Astrocytic Tumors
Show more Neurosciences

Amyloid and Tau PET

  • Evaluation of a visual read method for flortaucipir PET Scans
  • Sex Modulates the ApoE ε4 Effect on Tau 18F-AV-1451 PET Imaging in Individuals with Normal Aging and Mild Cognitive Impairment
Show more Amyloid and Tau PET

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire